MAXCYTE, INC.·4

Mar 29, 4:16 PM ET

Murphy Amanda Louise 4

4 · MAXCYTE, INC. · Filed Mar 29, 2022

Insider Transaction Report

Form 4
Period: 2022-03-25
Murphy Amanda Louise
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-25+142,000142,000 total
    Exercise: $7.12Exp: 2032-03-24Common Stock (142,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION